MUMBAI, India, Oct. 12 -- Intellectual Property India has published a patent application (202617048140 A) filed by Icosavax, Inc. on April 15, 2026, for Respiratory Syncytial Virus F Proteins And Nanostructures And Uses Thereof.
Inventors include Ellis, Daniel; and Dowling, Quinton.
The application for the patent was published on October 09, 2026, under issue no. 41/2026.
Abstract: Provided herein are recombinant polypeptides comprising an engineered ectodomain of a Respiratoiy Syncytial Virus (RSV) fusion (F) protein, wherein the ectodomain comprises an engineered C -terminal alpha-helical segment and/or amino acid substitutions that stabilize the F protein in a prefusion conformation. The disclosure also provides a two-component protei...